Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Muhammad U Siddiqui"'
Autor:
Muhammad U. Siddiqui, Eric Warner, Joey Junarta, Parker O’Neill, David Signarovitz, Eyad Kanawati, Mohammed Murtaza, David Fischman
Publikováno v:
Journal of Interventional Cardiology, Vol 2024 (2024)
Background. Studies have demonstrated poor prognosis in cancer patients who undergo percutaneous coronary intervention (PCI) for coronary artery disease (CAD). Cancer patients receiving PCI are at increased risk of in-stent thrombosis, bleeding, hosp
Externí odkaz:
https://doaj.org/article/32a6286d8f8b4ccdbdd7e94f03466013
Autor:
Muhammad U. Siddiqui, Joey Junarta, Joshua M. Riley, Adnan Ahmed, Ahmed K. Pasha, Kolin Limbrick, Rene J. Alvarez, Daniel R. Frisch
Publikováno v:
Journal of Arrhythmia, Vol 38, Iss 6, Pp 981-990 (2022)
Abstract Background Catheter ablation for atrial fibrillation (AF) is a proven alternative to pharmacologic rhythm control in patients with heart failure with reduced ejection fraction (HFrEF). Whether outcomes differ in patients with heart failure w
Externí odkaz:
https://doaj.org/article/f7ed2eacc0b14332a2ed85e16d2d9627
Autor:
Muhammad U. Siddiqui, Joey Junarta, Swaminathan Sathyanarayanan, Kirpal Kochar, Waqas Ullah, David L. Fischman
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 45, Iss , Pp 101191- (2023)
Background: Colchicine has anti-inflammatory properties, but its utility in improving cardiovascular outcomes has been disputed. Here, we study the impact of colchicine on cardiovascular outcomes in patients with gout with and without coronary artery
Externí odkaz:
https://doaj.org/article/b40fb5696131435580c3bbc4d057c9ac
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 4 (2022)
Background Coronary artery disease (CAD) is highly prevalent in patients with chronic kidney disease and is a common cause of mortality in end‐stage renal disease. Thus, patients with end‐stage renal disease are routinely screened for CAD before
Externí odkaz:
https://doaj.org/article/f414216aca364e9eb5e417ca6f497ba6
Autor:
Joey Junarta, Muhammad U Siddiqui, Joshua M Riley, Sean J Dikdan, Akash Patel, Daniel R Frisch
Publikováno v:
EP Europace. 24:1585-1598
Aims The value of additional ablation beyond pulmonary vein isolation for atrial fibrillation (AF) ablation is unclear, especially for persistent AF. The optimal target for substrate modification to improve outcomes is uncertain. We investigate the u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a476162edaf10af51e6a0afed44a782f
https://doi.org/10.1093/europace/euac089
https://doi.org/10.1093/europace/euac089
Publikováno v:
Cardiology Research and Practice, Vol 2019 (2019)
Introduction. Atrial fibrillation leads to increased risk of systemic embolism and stroke. To decrease these adverse events, anticoagulation is routinely prescribed. Nonvitamin K anticoagulants like apixaban and rivaroxaban are becoming popular and b
Externí odkaz:
https://doaj.org/article/8650d7bed2964e72a8bc315e35a2a411
Autor:
Joshua M. Riley, Joey Junarta, Waqas Ullah, Muhammad U. Siddiqui, Alexander Anzelmi, Max Ruge, Alec Vishnevsky, Rene J. Alvarez, Nicholas J. Ruggiero, Indranee N. Rajapreyar, Yevgeniy Brailovsky
Publikováno v:
The American Journal of Cardiology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::242dc1be8e5bc9691df2823d03e53912
https://doi.org/10.1016/j.amjcard.2023.04.003
https://doi.org/10.1016/j.amjcard.2023.04.003
Autor:
Sheikh Mohammed Shariful Islam, Clara K Chow, Reza Daryabeygikhotbehsara, Narayan Subedi, Jonathan Rawstorn, Teketo Tegegne, Chandan Karmakar, Muhammad U Siddiqui, Gavin Lambert, Ralph Maddison
Publikováno v:
European Heart Journal - Digital Health. 3:323-337
Aims High blood pressure (BP) is the commonest modifiable cardiovascular risk factor, yet its monitoring remains problematic. Wearable cuffless BP devices offer potential solutions; however, little is known about their validity and utility. We aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca9027ec12368e103ef00e2d8bb7a819
https://doi.org/10.1093/ehjdh/ztac021
https://doi.org/10.1093/ehjdh/ztac021
Publikováno v:
Circulation. 144
Introduction: Coronary artery disease (CAD) is a common cause of mortality in end stage renal disease and is highly prevalent in patients with chronic kidney disease. Therefore, patients with end stage renal disease are routinely screened for heart d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::962c9336e046c00eeee061df5183a32f
https://doi.org/10.1161/circ.144.suppl_1.11565
https://doi.org/10.1161/circ.144.suppl_1.11565
Publikováno v:
Circulation. 144
Background: Catheter ablation for atrial fibrillation is a proven alternative to pharmacologic rhythm control in patients with heart failure with reduced ejection fraction (HFrEF). Whether outcomes differ in patients with heart failure with preserved
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5e3101a59c57e7b2f5bf1f836c400d4
https://doi.org/10.1161/circ.144.suppl_1.10228
https://doi.org/10.1161/circ.144.suppl_1.10228